医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
RYTM · RHYTHM PHARMACEUTICALS, INC.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
RHYTHM PHARMACEUTICALS, INC.（RYTM）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $28.8M；高管董事有效买入 —、有效卖出 —。最近申报 2026-09-14。
买入 Bought—
卖出 Sold$28.8M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-09-14 | Meeker David P Director, President and CEO | 卖出 Sell | 50,000 | $102.67 | $5.1M | SEC |
| 2026-08-31 | Smith Hunter C Chief Financial Officer | 卖出 Sell | 62,774 | $105.46 | $6.6M | SEC |
| 2026-08-13 | Garfield Alastair Chief Scientific Officer | 卖出 Sell | 7,763 | $117.57 | $913K | SEC |
| 2026-08-13 | Shulman Joseph Chief Technical Officer | 卖出 Sell | 5,079 | $119.75 | $608K | SEC |
| 2026-08-13 | Lee Jennifer Kayden EVP, Head of North America | 卖出 Sell | 75,834 | $117.38 | $8.9M | SEC |
| 2026-08-12 | Mazabraud Yann EVP, Head of International | 卖出 Sell | 57,000 | $116.15 | $6.6M | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-14 | Meeker David P Director, Officer | 50,000 | $5.2M | 10b5-1 |
| 2026-08-31 | Smith Hunter C Officer | 62,774 | $6.7M | 10b5-1 |
| 2026-08-13 | Lee Jennifer Kayden Officer | 75,834 | $8.9M | 10b5-1 |
| 2026-08-13 | Garfield Alastair Officer | 7,763 | $913K | 10b5-1 |
| 2026-08-13 | Shulman Joseph Officer | 5,079 | $597K | 10b5-1 |
| 2026-08-12 | Mazabraud Yann Officer | 57,000 | $6.4M | 10b5-1 |
| 2026-08-11 | Cramer Pamela J. Officer | 11,406 | $1.3M | 10b5-1 |
| 2026-08-10 | Cramer Pamela J. Officer | 3,520 | $407K | 10b5-1 |
内部人 Insiders
Meeker David P、Smith Hunter C、Garfield Alastair、Shulman Joseph、Lee Jennifer Kayden、Mazabraud Yann